Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis.
about
Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.Pharmacokinetics and clearance processes of UK-279,276 (rNIF) in rat and dog: comparison with human data.Antagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy.Determination of the starting dose in the first-in-human clinical trials with monoclonal antibodies: a systematic review of papers published between 1990 and 2013Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates.Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.Ectopic expression of human mTOR increases viability, robustness, cell size, proliferation, and antibody production of chinese hamster ovary cells.A population pharmacokinetic-pharmacodynamic analysis of single doses of clenoliximab in patients with rheumatoid arthritis.Immunogenicity screening in protein drug development.
P2860
Q30699740-46544AA9-9DFC-4B65-8645-9D752A0E7A2BQ31039868-395B16D9-8044-408C-AF91-2F87EFF32F8EQ35036412-E678E39D-E35A-4A5D-9626-E67BA7210862Q37496388-1BC47BF0-9FF5-432E-BCF8-80E369D6E412Q38286209-C50281E9-D8DE-47A9-A195-95660004C2A4Q38675620-55F2B5FB-946C-4001-9627-14195E5B5A7CQ39576071-227900DE-242B-4444-B49E-50AEEB96898EQ40794894-89AE50E9-2CA8-49F5-9EBC-49FFE1549DB7Q49168236-B66C3A2E-7531-4F4C-A55C-BE2B3BFFEA63
P2860
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis.
@en
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis.
@nl
type
label
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis.
@en
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis.
@nl
prefLabel
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis.
@en
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis.
@nl
P2093
P1476
Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis.
@en
P2093
Maravilla KR
Petersdorf SH
Richards TL
St John TP
P304
P356
10.1016/S0009-9236(98)90183-7
P407
P577
1998-09-01T00:00:00Z